The medicine significantly reduced nasal polyp size, nasal congestion severity, and the need for systemic corticosteroids and/or surgery. In both trials, patients treated with Dupixent added to a ...

The CHMP opinion covers use of Dupixent with intranasal corticosteroids – the standard first-line treatment - in adults with the condition. In CRSwNP polyps obstruct the sinuses and nasal ...

The need for systemic corticosteroids fell by 88%, and the need for surgery fell by 98%. Nasal polyp and congestion scores fell, along with loss of smell and total symptom scores. SAN DIEGO ...

Mometasone is a corticosteroid demonstrating potent anti ... allergic rhinitis symptoms in patients ≥12yrs of age. Nasal polyps. Allergic rhinitis: ≥12yrs: 2 sprays in each nostril once ...

Nasal steroid sprays are used to treat chronic sinusitis and allergies that affect your breathing, like hay fever. They can also be used to treat snoring and nasal polyps, noncancerous growths in ...

In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

The US Food and Drug Administration (FDA) has approved the first biosimilar form of omalizumab (Xolair) for the treatment of a range of allergic conditions. Omalizumab-igec (Omlyclo) is designed ...

Results from a drug trial showed AstraZeneca and Amgen's new drug Tezspire significantly reduced nasal polyp severity, the need for surgery and anti-inflammatory steroid use in patients with ...

had received prior treatment with systemic corticosteroids (SCS), or were intolerant to SCS (N=528). Results showed patients treated with depemokimab had significant improvements in nasal polyp ...

Others: This category includes antihistamines and other medications that assist in managing symptoms associated with nasal polyps. In 2020, the corticosteroids segment dominated the market ...